Research article · 3 Mar 2022
Review articlePublished 29 Dec 2022
Depression-an Open Label Comparative Study
Senior Resident Institute of Mental Health and Neuroscience, Kashmir, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
While Naltrexone is a competitive receptor antagonist, buprenorphine is a partial mu-opioid agonist and kappa antagonist. By removing opioids from the receptors, the partial agonist activity of buprenorphine can induce withdrawal in opioid dependent patients. It is regulated sublingually, sublingual, Though Naltrexone has a more prominent partiality for μ receptors than heroin and other narcotic agonists. Utilizing buprenorphine and naltrexone for treatment aims to reduce illicit opioid use and increase treatment retention. Naltrexone and buprenorphine maintenance treatment has been started in opiate-dependent people, and the goal of our study was to see if there was a link between depression and the medication.At 2, 4, and 6 weeks, the Naltrexone group's depressive mood was significantly higher than the Buprenorphine group's. The Naltrexone group had significantly more insomnia, psychiatric and somatic anxiety, hypochondriasis,and gastrointestinal symptoms than the Buprenorphine group did. It was discovered that buprenorphine has an antidepressant effect.We concluded from our research that Buprenorphine was associated with higher HAM-D scores and Naltrexone was associated with depression.
Subjects
Mental Health and PsychologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2017
Effects of Fluvoxamine on Cognitive Function in Outpatients with Depression in Remission: Results of an Open-Label Pilot Study
Research article · 2015
Role of Amisulpride Augmentation in Treatment Resistant Major Depressive Disorder: An Open Label Study from North India
Research article · 26 Nov 2012
ESCITALOPRAM AND MIRTAZAPINE FOR THE TREATMENT OF DEPRESSION IN HIV PATIENTS: A RANDOMIZED CONTROLLED OPEN LABEL TRIAL
Research article · 22 Aug 2010
CAN DARK CHOCOLATE ALLEVIATE ANXIETY, DEPRESSIVE AND STRESS SYMPTOMS AMONG TRAINEE NURSES? A PARALLEL, OPEN-LABEL STUDY
More from this journal
The newest in Journal of Addiction Research & Therapy.
Commentary · 28 Feb 2026
Regional Drink Bacanora from a Gender Perspective
Research article · 31 Dec 2025
Association between Depressive Symptoms and Lifetime Cannabis Use among American Adolescents: Analysis of 2022 National Surveys on Drug Use and Health
Opinion · 30 Jun 2025
Public Health Implications of Cannabis Legalization: A Post-Legislation Trend Analysis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Addiction Research & Therapy
- SubjectMental Health and Psychology
- BylineArticles whose byline prints “Neelofar J”
- BylineArticles whose byline prints “Insha MK”
